Multizine Plus 2 mg/50 mg/5 mg Tablet
By Multizine Plus
Rx
10 Tablet in a Strip

Composition
Trihexyphenidyl(2mg) + Thioridazine(50mg) + Trifluoperazine(5mg)

Manufacturer - Triko Pharmaceuticals
152, I.d.c., Inudstrial Area, Rohtak - 124001, Rohtak

Expires on or after
June, 2026

liver
Limited information is present regarding the usage of Multizine Plus 2 mg/50 mg/5 mg Tablet in individuals with liver disease. It is crucial to consult with your doctor before using this medication. Based on the current data, Multizine Plus 2 mg/50 mg/5 mg Tablet is deemed unsafe for patients with liver disease. It is advisable to seek medical advice and explore alternative options if you have liver issues before considering this medication.

kidney
Consult your doctor for proper guidance before using Multizine Plus 2 mg/50 mg/5 mg Tablet in patients with kidney disease.

alcohol
It's not safe to drink alcohol while taking Multizine Plus 2 mg/50 mg/5 mg Tablet. Make sure to avoid alcohol consumption with this medication.

driving
When taking Multizine Plus 2 mg/50 mg/5 mg Tablet, be cautious while driving as it may cause dizziness, drowsiness, or blurred vision which can impact your ability to drive safely.

pregnancy
Multizine Plus 2 mg/50 mg/5 mg Tablet may not be safe to use during pregnancy. Limited human studies show possible harms to the baby. Consult your doctor for a careful evaluation before using.

breastfeeding
Caution should be taken while using Multizine Plus 2 mg/50 mg/5 mg Tablet during breastfeeding. Limited data indicates potential harm to the baby as the drug can pass into breastmilk.
| Habit Forming | No |
| Chemical Class | - |
| Therapeutic Class | NEURO CNS |
| Action Class | - |
₹112.5
₹125
10% OFF
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 11-Feb-2025
